Name | Type | Posted | Actions |
|---|---|---|---|
Exhibit D 6Mar25.docx | DOCX | Mar 6, 2025 | |
Exhibit C 6Mar25.docx | DOCX | Mar 6, 2025 | |
Exhibit B 6Mar25.docx | DOCX | Mar 6, 2025 | |
Exhibit A 6Mar25.docx | DOCX | Mar 6, 2025 | |
Exhibit E 6Mar25.docx | DOCX | Mar 6, 2025 | |
HT940625R0004 Conformed P00003.pdf | Mar 6, 2025 | ||
Exhibit E 25Feb25.docx | DOCX | Feb 25, 2025 | |
Exhibit D 25Feb25.docx | DOCX | Feb 25, 2025 | |
Exhibit C 25Feb25.docx | DOCX | Feb 25, 2025 | |
Exhibit B 25Feb25.docx | DOCX | Feb 25, 2025 | |
Exhibit A 25Feb25.docx | DOCX | Feb 25, 2025 | |
HT940625R0004 Conformed P00002.pdf | Feb 25, 2025 | ||
HT940625R0004 Conformed.pdf | Feb 13, 2025 | ||
Exhibit E.docx | DOCX | Feb 13, 2025 | |
Exhibit D.docx | DOCX | Feb 13, 2025 | |
Exhibit C.docx | DOCX | Feb 13, 2025 | |
Exhibit B.docx | DOCX | Feb 13, 2025 | |
Exhibit A.docx | DOCX | Feb 13, 2025 | |
Exhibit B.docx | DOCX | Feb 10, 2025 | |
Exhibit C.docx | DOCX | Feb 10, 2025 | |
Exhibit D.docx | DOCX | Feb 10, 2025 | |
Exhibit E.docx | DOCX | Feb 10, 2025 | |
HT940625R0004.pdf | Feb 10, 2025 | ||
Exhibit A.docx | DOCX | Feb 10, 2025 |
Radiopharmaceuticals - Naval Medical Center Portsmouth
Contact and place of performance
Carol Uebelacker
Portsmouth, VA 23708
USA
Defense Health Agency (DHA) has a requirement for a Firm Fixed Price (FFP) IDIQ supply contract in accordance with FAR Part 12, Commercial Items and FAR Part 13, Simplified Acquisition Procedures for General Nuclear Medicine Radiopharmaceuticals (GNMR) at Naval Medical Center Portsmouth (NMCP) VA. In order to be considered for this requirement, please respond with a completed proposal following the guidelines starting on page 3 of the SF1449.
The Defense Health Agency (DHA) has issued solicitation HT940625R0004 for a firm-fixed-price, indefinite-delivery/indefinite-quantity (IDIQ) supply contract. This requirement covers general nuclear medicine radiopharmaceuticals (GNMR) to be delivered to the Naval Medical Center Portsmouth (NMCP) in Portsmouth, Virginia. The acquisition is classified under NAICS 325412, Pharmaceutical Preparation Manufacturing, and PSC 6505, Drugs and Biologicals.
The procurement is being conducted in accordance with simplified acquisition procedures for commercial items. To be considered for an award, interested parties must submit a completed proposal following the specific guidelines provided within the solicitation documentation. The notice includes 24 attachments, such as multiple exhibits updated on March 6, 2025, and a conformed copy of the solicitation.
Proposals are due by March 11, 2025. Carol Uebelacker serves as the primary point of contact for this requirement. The performance location is restricted to the naval medical facilities in Portsmouth, Virginia.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.